By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Researchers at four universities led by the Boston University School of Medicine will use a five year, $3.3 million grant to build up core services for conducting biomarker-focused research into systemic sclerosis (SSc), also called scleroderma, a rare and complex rheumatic disease that can cause scarring and vascular disease in multiple organs.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.